Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
10,565 | $47.88 | $505,856 | 65,057 (Direct) |
View |
2024-03-18 Sale |
2024-03-19 7:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,766 | $30.6 | $145,840 | 88,099 (Direct) |
View |
2023-07-19 Sale |
2023-07-21 5:46 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
2,400 | $20.05 | $48,120 | 45,806 (Direct) |
View |
2023-06-08 Sale |
2023-06-12 5:25 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
100 | $20 | $2,000 | 48,086 (Direct) |
View |
2023-06-06 Sale |
2023-06-08 7:16 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,643 | $19 | $88,231 | 48,186 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:46 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
1,078 | $12.55 | $13,531 | 52,829 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
697 | $12.94 | $9,016 | 53,907 (Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:17 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
336 | $13.43 | $4,512 | 68,974 (Direct) |
View |
2022-11-15 Sale |
2022-11-17 5:30 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
6,857 | $17.72 | $121,506 | 49,729 (Direct) |
View |
2021-11-08 Sale |
2021-11-10 6:29 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
1,889 | $28.11 | $53,100 | 50,203 (Direct) |
View |
2021-11-04 Sale |
2021-11-08 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
111 | $28.04 | $3,112 | 52,092 (Direct) |
View |
2021-11-02 Sale |
2021-11-04 7:03 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
6,000 | $26.78 | $160,690 | 52,203 (Direct) |
View |
2021-09-10 Sale |
2021-09-14 4:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
2,593 | $22.15 | $57,435 | 73,964 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-15 Exercise |
2025-03-18 9:38 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
41,914 | $0 | 120,768 (Direct) |
View |
2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
55,789 | $0 | 55,789 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 7:08 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
25,876 | $0 | 88,099 (Direct) |
View |
2024-03-07 Option Award |
2024-03-11 5:12 pm |
N/A 2034-03-06 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
79,579 | $0 | 79,579 (Direct) |
View |
2023-03-15 Exercise |
2023-03-17 6:17 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,790 | $0 | 68,974 (Direct) |
View |
2023-03-08 Option Award |
2023-03-10 7:25 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
80,708 | $0 | 80,708 (Direct) |
View |
2022-08-24 Exercise |
2022-08-26 4:25 pm |
N/A 2028-09-13 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
772 | $0.45 | 67,159 (Direct) |
View |
2022-08-24 Exercise |
2022-08-26 4:25 pm |
N/A 2030-09-24 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,416 | $10.99 | 67,159 (Direct) |
View |
2022-03-09 Option Award |
2022-03-11 4:10 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
84,472 | $0 | 84,472 (Direct) |
View |
2021-09-10 Exercise |
2021-09-14 4:51 pm |
N/A 2028-09-13 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
2,593 | $0.45 | 73,964 (Direct) |
View |
2021-09-10 Exercise |
2021-09-14 4:51 pm |
N/A 2030-09-24 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,350 | $10.99 | 73,964 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 4:55 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
40,999 | $0 | 40,999 (Direct) |
View |
Ownership |
2020-10-15 8:13 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
0 | $0 | 127,492 (Direct) |
View |